Clinical Trial Update: Ranibizumab for Polypoidal Choroidal Vasculopathy (PCV) [Phase 1]

View source ↗

Summary

This document reports the completion of a Phase 1 trial evaluating ranibizumab for polypoidal choroidal vasculopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polypoidal Choroidal Vasculopathy

Drugs mentioned

• Ranibizumab (ranibizumab)

Snippet

Sponsor: Hawaii Pacific Health | Conditions: Polypoidal Choroidal Vasculopathy | Phase 1 | Status: COMPLETED